ReviewCell communication and signaling : CCS2026
Hemifusomes and proteolipid nanodroplets: a critical synthesis of an emerging model for endosomal membrane remodeling.
Review in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vesicular membrane trafficking is central to eukaryotic homeostasis, governing receptor downregulation, lysosomal degradation, and intercellular communication via exosomes. These processes are classically explained by SNARE-mediated fusion and ESCRT-dependent membrane remodeling, which together define current models of vesicle biogenesis and multivesicular body (MVB) formation. Recent high-resolution cryo-electron tomography of intact mammalian cells has identified a structurally distinct membrane-associated assembly termed the hemifusome. Hemifusomes consist of two heterotypic vesicles connected by a persistent hemifusion diaphragm (~ 160 nm in diameter) and feature a ~ 42 nm proteolipid nanodroplet (PND) localized at the diaphragm rim. This architecture expands current views of hemifusion intermediates and raises the possibility of an alternative mode of endosomal membrane organization distinct from canonical ESCRT-mediated processes. However, the molecular composition, biogenesis, and regulatory mechanisms of this system remain undefined. Here, we provide the first integrated synthesis of hemifusome and PND biology, consolidating structural, biophysical, and mechanistic observations within the context of endosomal trafficking. We compare this emerging framework with ESCRT-mediated intraluminal vesicle formation, highlighting both shared features and key mechanistic gaps. We further examine preliminary and largely correlative links to neurodegenerative and lysosomal storage disorders, while emphasizing the absence of direct causal evidence. Given that this field currently rests on a single primary research report, we deliberately separate this evidence-based structural synthesis from more speculative functional, disease-related, and translational extensions, which are presented as explicit future perspectives rather than established conclusions. Finally, we outline unresolved questions, including PND molecular identity, determinants of hemifusion diaphragm organization and stability, and the temporal sequence of hemifusome assembly and remodeling. Together, these findings position hemifusomes as a potentially distinct structural state within the endosomal network, warranting systematic molecular and functional investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.